Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury
Fecha de Publicación: 9 de octubre, 2020 Referencia Muñoz AE, Pollarsky F, Marino M, Cartier M, Míguez C, Vázquez H, Álvarez D, Salgado P, Romero G. Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury. Dig Dis Sci. 2020 Oct 9. Resumen general La alta tasa de mortalidad de la cirrosis descompensada subraya la necesidad de
Share: